ArticleOncoTargets and therapy2020

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy.

Chunmei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.